The role of cigarette smoking on new-onset of chronic kidney disease in a Japanese population without prior chronic kidney disease: Iki epidemiological study of atherosclerosis and chronic kidney disease (ISSA-CKD)

被引:24
作者
Ito, Kenji [1 ]
Maeda, Toshiki [2 ]
Tada, Kazuhiro [1 ,2 ]
Takahashi, Koji [1 ]
Yasuno, Tetsuhiko [1 ]
Masutani, Kosuke [1 ]
Mukoubara, Shigeaki [3 ]
Arima, Hisatomi [2 ]
Nakashima, Hitoshi [1 ]
机构
[1] Fukuoka Univ, Div Nephrol & Rheumatol, Dept Internal Med, Fac Med,Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan
[2] Fukuoka Univ, Fac Med, Dept Prevent Med & Publ Hlth, Fukuoka, Japan
[3] Nagasaki Prefecture Iki Hosp, Iki, Japan
基金
日本学术振兴会;
关键词
Chronic kidney disease; Smoking; Estimated glomerular filtration rate; Proteinuria; Japanese epidemiological study; HEALTHY LIFE-STYLE; INSULIN-RESISTANCE; RISK-FACTORS; ALL-CAUSE; PROGRESSION; PROTEINURIA; MORTALITY; EVENTS; DEATH;
D O I
10.1007/s10157-020-01914-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Studies regarding harmful effects of smoking on the new-onset of chronic kidney disease (CKD) have been limited. Thus, we collected and retrospectively studied 8 years of data from the annual health check-ups of the residents in Iki City (Nagasaki Prefecture, Japan). Methods From 2008 to 2016, 4540 adults were enrolled in the study. Information on smoking habits was obtained via a self-reported questionnaire. New-onset CKD was defined as a reduction of the estimated globular filtration rate (eGFR) to less than 60 mL/min/1.73 m(2)and/or new-onset proteinuria during the follow-up examinations. Results During an average follow-up of 4.6 years, proteinuria developed in 218 people (10.4 per 1000 person-years) and eGFR decline to less than 60 mL/min/1.73 m(2)was confirmed in 594 people (28.3 per 1000 person-years) including 53 who showed both proteinuria and eGFR reduction (2.8 per 1000 person-years). In terms of proteinuria, current smokers showed a higher incidence than non-smokers (14.1 and 9.17 per 1000 person-years, respectively,p = 0.001), and a significantly high hazard ratio (HR) of 1.39 with a 95% CI of 1.01-1.92 in multivariable Cox's proportional-hazard analyses. The tendency was more drastic among younger participants (p = 0.015 for trend): current smokers who were < 50 years old had a significantly higher HR of 2.55 with a 95% CI of 1.01-6.45 (p = 0.004) than non-smokers. Conclusions Smoking significantly increased the risk for new-onset of CKD based on proteinuria development in a Japanese population without CKD, and the association was more predominant in the younger population.
引用
收藏
页码:919 / 926
页数:8
相关论文
共 50 条
[41]   Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study [J].
Ninomiya, T ;
Kiyohara, Y ;
Kubo, M ;
Tanizaki, Y ;
Doi, Y ;
Okubo, K ;
Wakugawa, Y ;
Hata, J ;
Oishi, Y ;
Shikata, K ;
Yonemoto, K ;
Hirakata, H ;
Iida, M .
KIDNEY INTERNATIONAL, 2005, 68 (01) :228-236
[42]   Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease [J].
Joo, Young Su ;
Yun, Hae-Ryoung ;
Kim, Hyung Woo ;
Koh, Hee Byung ;
Jung, Chan-Young ;
Chang, Tae-Ik ;
Park, Jung Tak ;
Park, Sue Kyung ;
Hyun, Young Youl ;
Kim, Yeong Hoon ;
Sung, Suah ;
Yoo, Tae-Hyun ;
Oh, Kook-Hwan ;
Kang, Shin-Wook ;
Han, Seung Hyeok .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025, 40 (06) :1203-1212
[43]   Carotid ultrasound for the early diagnosis of atherosclerosis in chronic kidney disease [J].
Betriu-Bars, Angels ;
Fernandez-Giraldez, Elvira .
NEFROLOGIA, 2012, 32 (01) :7-11
[44]   The risk of atherosclerosis in patients with chronic kidney disease [J].
Olechnowicz-Tietz, Sylwia ;
Gluba, Anna ;
Paradowska, Anna ;
Banach, Maciej ;
Rysz, Jacek .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2013, 45 (06) :1605-1612
[45]   Smoking habit as a risk amplifier in chronic kidney disease patients [J].
Provenzano, Michele ;
Serra, Raffaele ;
Michael, Ashour ;
Bolignano, Davide ;
Coppolino, Giuseppe ;
Ielapi, Nicola ;
Serraino, Giuseppe Filiberto ;
Mastroroberto, Pasquale ;
Locatelli, Francesco ;
De Nicola, Luca ;
Andreucci, Michele .
SCIENTIFIC REPORTS, 2021, 11 (01)
[46]   Prevalence of chronic kidney disease in the Japanese general population [J].
Enyu Imai ;
Masaru Horio ;
Tsuyoshi Watanabe ;
Kunitoshi Iseki ;
Kunihiro Yamagata ;
Shigeko Hara ;
Nobuyuki Ura ;
Yutaka Kiyohara ;
Toshiki Moriyama ;
Yasuhiro Ando ;
Shoichi Fujimoto ;
Tsuneo Konta ;
Hitoshi Yokoyama ;
Hirofumi Makino ;
Akira Hishida ;
Seiichi Matsuo .
Clinical and Experimental Nephrology, 2009, 13 :621-630
[47]   The role of uric acid in chronic kidney disease patients [J].
Hsieh, Yao-Peng ;
Chang, Chia-Chu ;
Yang, Yu ;
Wen, Yao-Ko ;
Chiu, Ping-Fang ;
Lin, Chi-Chen .
NEPHROLOGY, 2017, 22 (06) :441-448
[48]   The role of calcium antagonists in chronic kidney disease [J].
Gashti, CN ;
Bakris, GL .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2004, 13 (02) :155-161
[49]   Growth in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study [J].
Rodig, Nancy M. ;
McDermott, Kelly C. ;
Schneider, Michael F. ;
Hotchkiss, Hilary M. ;
Yadin, Ora ;
Seikaly, Mouin G. ;
Furth, Susan L. ;
Warady, Bradley A. .
PEDIATRIC NEPHROLOGY, 2014, 29 (10) :1987-1995
[50]   Impact of prior stroke on major clinical outcome in chronic kidney disease: the Salford kidney cohort study [J].
Tollitt, James ;
Odudu, Aghogho ;
Flanagan, Emma ;
Chinnadurai, Rajkumar ;
Smith, Craig ;
Kalra, Philip A. .
BMC NEPHROLOGY, 2019, 20 (01)